• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

医院工作人员自行接种皮内流感疫苗与护士接种肌内流感疫苗在效率、满意度及不良事件方面的差异。

Differences in efficiency, satisfaction and adverse events between self-administered intradermal and nurse-administered intramuscular influenza vaccines in hospital workers.

作者信息

Coleman Brenda L, McNeil Shelly A, Langley Joanne M, Halperin Scott A, McGeer Allison J

机构信息

Mount Sinai Hospital, 600 University Avenue, Toronto, ON, Canada; University of Toronto, 155 College Street, Toronto, ON, Canada.

Canadian Center for Vaccinology, Dalhousie University, 6299 South Street, Halifax, NS, Canada; QE II Health Sciences Centre, Nova Scotia Health Authority, 1276 South Park Street, Halifax, NS, Canada.

出版信息

Vaccine. 2015 Nov 27;33(48):6635-40. doi: 10.1016/j.vaccine.2015.10.095. Epub 2015 Oct 31.

DOI:10.1016/j.vaccine.2015.10.095
PMID:26529074
Abstract

UNLABELLED

Vaccinating healthcare workers against influenza takes tens of thousands of hours of work annually. This study was undertaken to determine the acceptability, success rate, and time to vaccinate healthcare workers in nurse-led groups that self-vaccinated with intradermal influenza vaccine compared with nurse-administered intramuscular vaccine.

METHODS

Volunteer hospital workers were randomly assigned to groups that either self-administered intradermal influenza vaccine (Intanza(®)) in a nurse-led group or received nurse-administered intramuscular vaccine (Vaxigrip(®)). Research assistants timed vaccination procedures; pre- and post-injection questionnaires assessed acceptability and reactogenicity.

RESULTS

810 adults, 21-69 years of age, from two study sites were vaccinated: 401 self-administered the intradermal vaccine while 409 received their intramuscular vaccine from a nurse. Of those who self-administered for the first time, 98.5% were successful on their first attempt with an additional 1.5% on their second attempt. Acceptability was high: 96% were very or somewhat certain that they administered the vaccine correctly, 83% would choose intradermal influenza vaccine again and of those, 75% would choose self-administration again, if given the choice. It took 51.3-72.6s per person for the nurses to guide the groups through the self-administration process, which was significantly less time than it took to individually administer the intramuscular vaccines (93.6s).

CONCLUSION

Self-administration of intradermal influenza vaccine by people working in healthcare settings is a possible alternative to nurse administered vaccinations, with nurse-led group sessions a good way of teaching the technique while being available to respond to unanticipated problems (NCT01665807).

摘要

未标注

每年为医护人员接种流感疫苗需要耗费数万小时的工作时间。本研究旨在确定由护士指导的小组中,医护人员自行接种皮内流感疫苗与由护士接种肌内注射疫苗相比的可接受性、成功率及接种时间。

方法

志愿参与的医院工作人员被随机分为两组,一组在护士指导下自行接种皮内流感疫苗(Intanza(®)),另一组接受护士接种的肌内注射疫苗(Vaxigrip(®))。研究助手记录接种程序的时间;注射前后的问卷评估可接受性和反应原性。

结果

来自两个研究地点的810名年龄在21至69岁的成年人接种了疫苗:401人自行接种皮内疫苗,409人由护士接种肌内疫苗。首次自行接种的人中,98.5%首次尝试成功,另有1.5%在第二次尝试时成功。可接受性较高:96%的人非常确定或有些确定自己正确接种了疫苗,83%的人会再次选择皮内流感疫苗,其中75%的人如果可以选择,会再次选择自行接种。护士指导小组进行自行接种过程,每人耗时51.3 - 72.6秒,这明显少于单独接种肌内疫苗所需的时间(93.6秒)。

结论

医疗机构工作人员自行接种皮内流感疫苗是护士接种疫苗的一种可行替代方法,由护士指导的小组会议是教授该技术的好方法,同时可随时应对意外问题(NCT01665807)。

相似文献

1
Differences in efficiency, satisfaction and adverse events between self-administered intradermal and nurse-administered intramuscular influenza vaccines in hospital workers.医院工作人员自行接种皮内流感疫苗与护士接种肌内流感疫苗在效率、满意度及不良事件方面的差异。
Vaccine. 2015 Nov 27;33(48):6635-40. doi: 10.1016/j.vaccine.2015.10.095. Epub 2015 Oct 31.
2
A randomized control trial comparing immunogenicity, safety, and preference for self- versus nurse-administered intradermal influenza vaccine.一项比较免疫原性、安全性以及患者对自我皮下注射和护士辅助皮下注射流感疫苗偏好的随机对照试验。
Vaccine. 2012 Sep 28;30(44):6287-93. doi: 10.1016/j.vaccine.2012.08.006. Epub 2012 Aug 16.
3
Immunogenicity and safety of Intanza(®)/IDflu(®) intradermal influenza vaccine in South Korean adults: a multicenter, randomized trial.Intanza(®)/IDflu(®)皮内流感疫苗在韩国成年人中的免疫原性和安全性:一项多中心随机试验
Hum Vaccin Immunother. 2013 Sep;9(9):1971-7. doi: 10.4161/hv.25295. Epub 2013 Jun 18.
4
Influenza vaccination in healthcare workers; comparison of side effects and preferred route of administration of intradermal versus intramuscular administration.医护人员的流感疫苗接种;皮内注射与肌肉注射的副作用比较及首选给药途径
Vaccine. 2017 Mar 13;35(11):1517-1523. doi: 10.1016/j.vaccine.2017.01.065. Epub 2017 Feb 10.
5
Randomized Controlled Trial to Compare Immunogenicity of Standard-Dose Intramuscular Versus Intradermal Trivalent Inactivated Influenza Vaccine in HIV-Infected Men Who Have Sex With Men in Bangkok, Thailand.泰国曼谷男男性行为艾滋病毒感染者中标准剂量肌内注射与皮内注射三价灭活流感疫苗免疫原性比较的随机对照试验。
Clin Infect Dis. 2016 Feb 1;62(3):383-391. doi: 10.1093/cid/civ884. Epub 2015 Oct 20.
6
Immunogenicity, large scale safety and lot consistency of an intradermal influenza vaccine in adults aged 18-60 years: Randomized, controlled, phase III trial.18至60岁成年人皮内注射流感疫苗的免疫原性、大规模安全性及批次一致性:随机对照III期试验
Hum Vaccin. 2010 Apr;6(4):346-54. doi: 10.4161/hv.6.4.10961. Epub 2010 Apr 15.
7
Intradermal influenza vaccination of healthy adults using a new microinjection system: a 3-year randomised controlled safety and immunogenicity trial.使用新型微量注射系统对健康成年人进行皮内流感疫苗接种:一项为期3年的随机对照安全性和免疫原性试验。
BMC Med. 2009 Apr 2;7:13. doi: 10.1186/1741-7015-7-13.
8
Intradermal influenza vaccine administered using a new microinjection system produces superior immunogenicity in elderly adults: a randomized controlled trial.使用新型微量注射系统接种的皮内流感疫苗在老年人中产生了更高的免疫原性:一项随机对照试验。
J Infect Dis. 2008 Sep 1;198(5):650-8. doi: 10.1086/590434.
9
Acceptance of Intanza® 9 μg intradermal influenza vaccine in routine clinical practice in Australia and Argentina.在澳大利亚和阿根廷的常规临床实践中接受 Intanza® 9μg 皮内流感疫苗。
Adv Ther. 2011 Aug;28(8):640-9. doi: 10.1007/s12325-011-0042-0. Epub 2011 Jul 11.
10
Direct comparison of an inactivated subvirion influenza A virus subtype H5N1 vaccine administered by the intradermal and intramuscular routes.皮内和肌肉途径接种灭活亚单位流感 A 病毒亚型 H5N1 疫苗的直接比较。
J Infect Dis. 2012 Oct 1;206(7):1069-77. doi: 10.1093/infdis/jis402. Epub 2012 Aug 13.

引用本文的文献

1
Chrono-tailored drug delivery systems: recent advances and future directions.时间定制药物传递系统:最新进展和未来方向。
Drug Deliv Transl Res. 2024 Jul;14(7):1756-1775. doi: 10.1007/s13346-024-01539-4. Epub 2024 Feb 28.
2
Incentivized self-vaccination for global measles eradication.通过激励措施实现自我接种以在全球根除麻疹。
J Virus Erad. 2022 Dec 15;8(4):100310. doi: 10.1016/j.jve.2022.100310. eCollection 2022 Dec.
3
Uptake rates, knowledge, attitudes, and practices toward seasonal influenza vaccination among healthcare workers in Lebanon.
黎巴嫩医护人员对季节性流感疫苗接种的接种率、知识、态度和实践。
Hum Vaccin Immunother. 2021 Nov 2;17(11):4623-4631. doi: 10.1080/21645515.2021.1948783. Epub 2021 Jul 22.
4
Influenza Vaccination and Guillain-Barré Syndrome: Reality or Fear.流感疫苗接种与吉兰-巴雷综合征:现实还是恐惧
J Transl Int Med. 2019 Dec 31;7(4):137-142. doi: 10.2478/jtim-2019-0028. eCollection 2019 Dec.
5
Immunogenicity, safety and tolerability of intradermal influenza vaccines.皮内流感疫苗的免疫原性、安全性和耐受性。
Hum Vaccin Immunother. 2018 Mar 4;14(3):565-570. doi: 10.1080/21645515.2017.1328332. Epub 2017 Jul 6.
6
Is There an Optimal Formulation and Delivery Strategy for Subunit Vaccines?亚单位疫苗是否存在最佳配方和递送策略?
Pharm Res. 2016 Sep;33(9):2078-97. doi: 10.1007/s11095-016-1979-0. Epub 2016 Jul 5.
7
Fluzone® intra-dermal (Intanza®/Istivac® Intra-dermal): An updated overview.流感病毒裂解疫苗(安尔来福/依维卡皮内注射剂):最新概述
Hum Vaccin Immunother. 2016 Oct 2;12(10):2616-2627. doi: 10.1080/21645515.2016.1187343. Epub 2016 May 31.